Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...

Frontier’s Wilmington hub will anchor North American operations, with Shannon, Ireland, leading efforts in Europe, the Middle ...

Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...

In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged ...

The move follows similar initiatives by players like Syngene, Laurus Labs, and Aragen. Industry analysts see Bharat Biotech’s ...